Back to Search
Start Over
Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.
- Source :
-
Diabetes care [Diabetes Care] 2017 Jun; Vol. 40 (6), pp. 808. Date of Electronic Publication: 2017 Apr 18. - Publication Year :
- 2017
Details
- Language :
- English
- ISSN :
- 1935-5548
- Volume :
- 40
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Diabetes care
- Publication Type :
- Academic Journal
- Accession number :
- 28420698
- Full Text :
- https://doi.org/10.2337/dc17-er06